Published • loading... • Updated
Ardena completes divestment of its Södertälje drug substance site in Sweden to Nanologica
Summary by The Toronto Star
8 Articles
8 Articles
+7 Reposted by 7 other sources
Ardena completes divestment of its Södertälje drug substance site in Sweden to Nanologica
Ghent, Belgium, 29th January 2026 – Ardena, a specialist CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, today announced that it has completed the divestment of its drug substance (API) site in Södertälje, Sweden, to Nanologica AB.…
Coverage Details
Total News Sources8
Leaning Left7Leaning Right1Center0Last UpdatedBias Distribution88% Left
Bias Distribution
- 88% of the sources lean Left
88% Left
L 88%
12%
Factuality
To view factuality data please Upgrade to Premium






